Distributor inventory | Tablet
Vildagliptin 100 mg + Metformin 1000 mg (Sustained/Extended Release)
Type 2 diabetes mellitus—used to improve blood glucose control in adults when diet and exercise alone are insufficient, often as add-on therapy.
Vildagliptin is a DPP-4 inhibitor that increases incretin hormones (GLP-1, GIP), thereby increasing insulin release and reducing glucagon in a glucose-dependent manner. Metformin reduces hepatic glucose production and improves insulin sensitivity; the SR form provides prolonged action with better GI tolerance.
Oral sustained-release tablet. Take exactly as prescribed, usually once daily with the evening meal or as advised. Swallow whole with water; do not crush, break, or chew. Take with food to reduce stomach upset; maintain diet/exercise and monitor glucose regularly.
Common side effects of VILDAPRIME M100/1000 SR TAB may include:
Prescription-only. Risk of lactic acidosis with metformin—seek urgent care for rapid breathing, severe weakness, muscle pain, abdominal pain, unusual sleepiness. Avoid in severe renal impairment; assess kidney function before start and periodically. Use caution in liver disease, alcoholism, dehydration, severe infection, hypoxia/heart failure. Stop temporarily before iodinated contrast imaging and major surgery as advised. Monitor for pancreatitis symptoms (severe persistent abdominal pain), and for vitamin B12 deficiency with long-term use. Not for type 1 diabetes or diabetic ketoacidosis.
